Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Heilongjiang Tianchen Pharmaceutical is a Chinese pharmaceutical company based in Harbin, specializing in the development and production of chemical drugs and traditional Chinese medicine. The company is recognized for its expertise in cardiovascular and cerebrovascular therapeutic areas, with a flagship product line centered on Alprostadil injections. Its manufacturing facilities are GMP-certified and equipped to produce various dosage forms, including large and small volume injections, tablets, and capsules. Tianchen focuses on the domestic Chinese market, positioning itself as a key provider of treatments for chronic vascular conditions and diabetic complications. The company integrates research, production, and sales to maintain its competitive standing in the regional pharmaceutical industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Heilongjiang Tianchen Pharmaceutical.